Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

Morgan L. Maeder, Michael Stefanidakis, Christopher J. Wilson, +34

Nature Medicine

Ocular DiseaseDevelopmental BiologyRetinaOphthalmologyGenetic Disorder +7

Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Maxwell N. Skor, Erin L. Wonder, Masha Kocherginsky, +4

Clinical Cancer Research

UDiTaS™, a genome editing detection method for indels and genome rearrangements

Georgia Giannoukos, Dawn Ciulla, Eugenio Marco, +11

BMC Genomics

Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer

Diana C. West, Masha Kocherginsky, Eva Tonsing-Carter, +20

Clinical Cancer Research

Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma

Erica Stringer-Reasor, Gabrielle M. Baker, Maxwell N. Skor, +4

Gynecologic Oncology

Chemotherapy-induced Cell DeathMedicineGynecologyPathologyCancer Treatment +4

Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression

Ben A. Hall, Tae Yeon Kim, Maxwell N. Skor, +1

Breast Cancer Research and Treatment

Breast OncologyOncologyEr-alpha ExpressionMedicineMtorc1 Activity +8

Chronic Social Isolation Is Associated with Metabolic Gene Expression Changes Specific to Mammary Adipose Tissue

Paul A. Volden, Erin L. Wonder, Maxwell N. Skor, +7

Cancer Prevention Research

Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor–Negative Mammary Epithelial Cell Proliferation

Paul A. Volden, Maxwell N. Skor, Marianna B. Johnson, +5

Cancer Prevention Research

GynecologyCellular PhysiologyMammary Gland DevelopmentSignaling PathwayAutophagy +16

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer

Rita Nanda, Erica Stringer-Reasor, Poornima Saha, +13

SpringerPlus

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer

Abena S. Agyeman, Wesley J. Jun, David A. Proia, +4

Hormones and Cancer

Hsp90 Inhibition ResultsBreast OncologyMedicinePharmacologyBreast Cancer +7